Carnobacteriocin A (CbnA) is a regulated bacteriocin produced by Carnobacterium piscicola LV17A that is encoded on a 72 kb plasmid. A 100 kb fragment from this plasmid that contained information necessary for bacteriocin production and immunity was cloned and sequenced. Genetic analysis showed the presence of the previously sequenced structural gene for CbnA, as well as genes encoding proteins homologous to dedicated bacteriocin transport proteins and proteins of three-component signal transduction systems. The induction factor (CbnX) was chemically synthesized and induced CbnA production at 10 N11 M or higher in a C. piscicola LV17A culture that had lost the ability to produce bacteriocin as a result of dilution. The gene cbiA for the immunity protein is not located in typical close proximity to the structural gene for CbnA and is encoded in the opposite orientation. CbiA has homology with EniB, the immunity protein for enterocin B that is also encoded in the opposite orientation to the bacteriocin gene. CbiA and EniB cross-protected against the corresponding bacteriocins.
INTRODUCTION
Lactic acid bacteria (LAB) produce a wide array of class II bacteriocins that have been classified by Klaenhammer (1993) and Nes et al. (1996) . These are small (4-6 kDa), heat-stable peptides that are ribosomally synthesized as inactive prebacteriocins, with either an N-terminal with the bacteriocin gene (Nes et al., 1996) . The immunity protein of class II bacteriocins protects the cell from its own bacteriocin. Despite the similarities observed for many class II bacteriocins, their immunity proteins share limited or no homology (Allison & Klaenhammer, 1996 ; Aymerich et al., 1996 ; Nes et al., 1996 ; Eijsink et al., 1998) . Production of several class IIa bacteriocins is regulated by a three-component regulatory system that is homologous to signal transduction systems in bacteria (Nes et al., 1996) . The components of this regulatory system consist of an induction factor, a histidine protein kinase and a response regulator (Nes et al., 1996) . Production of the plantaricins S, JK and EF by Lactobacillus plantarum strains (Diep et al., 1995 (Diep et al., , 1996 Anderssen et al., 1998 ; Stephens et al., 1998) , sakacins A and P by Lactobacillus sakei (Axelsson & Holck, 1995 ; Hu$ hne et al., 1996 ; Brurberg et al., 1997) , carnobacteriocin B2 by Carnobacterium piscicola LV17B (Quadri et al., 1997) , and enterocins A and B by Enterococcus faecium strains (Nilsen et al., 1998 ; O'Keeffe et al., 1999) , are regulated by three-component regulatory systems. C. piscicola LV17 produces three carnobacteriocins : A, BM1 and B2. The structural gene for carnobacteriocin BM1 (CbnBM1) is located on the chromosome and those for carnobacteriocins A (CbnA) and B2 (CbnB2) are located on 72 kb and 61 kb plasmids, respectively (Quadri et al., 1994 ; Worobo et al., 1994) . By curing and plasmid mobilization the plasmids were separated and introduced into the plasmidless host strain (LV17C) as LV17A and LV17B, respectively (Ahn & Stiles, 1992) . The immunity genes for CbnBM1 and CbnB2 are located in an operon with the respective prebacteriocin structural genes (Quadri et al., 1994) , but an immunity gene was not located in the same relative position for CbnA (Worobo et al., 1994) . This was similar to the case of enterocin B (EntB) production by Ent. faecium BFE 900, where the immunity gene was not located within the same operon (Franz et al., 1999) . We previously purified CbnA and localized the gene encoding precarnobacteriocin A on a 1n4 kb cloned fragment (Worobo et al., 1994) . In this study we describe the nucleotide sequence and genetic arrangement of the region downstream of the CbnA structural gene, and its relationship to immunity, dedicated bacteriocin transport and regulation of CbnA production. We also describe the fusion of the DNA encoding the signal peptide of the divergicin A gene to the part of the gene encoding mature CbnA, followed by the gene for CbiA. This study also reports cross-immunity between the CbnA and EntB immunity genes in the respective CbnA and EntB bacteriocin systems.
METHODS
Bacterial strains, plasmids and culture conditions. The bacterial strains and plasmids used in this study are described in Table 1 . Escherichia coli strains were grown in LuriaBertani broth (LB ; BBL, Becton Dickinson) at 37 mC on a rotary shaker at 250 r.p.m. Carnobacteria were grown in APT broth (All Purpose Tween ; Difco). Other LAB were grown in Lactobacilli MRS broth (Difco) at 25 mC without agitation. Stock cultures were prepared in the same media with 15 % (v\v) glycerol and stored at k80 mC. Antibiotics were added as selective agents when appropriate : erythromycin (200 µg ml − ") and ampicillin (150 µg ml − ") for E. coli, erythromycin (5 µg ml − ") or chloramphenicol (10 µg ml − ") for LAB.
Bacteriocin activity assays. Bacteriocin activity was quantified by the critical dilution method (Franz et al., 1999) , using heattreated (boiling water bath for 6 min) cell-free supernatant of the producer culture. Indicator bacteria from an overnight culture were inoculated (1 %) into APT soft agar (0n75 % agar). C. piscicola LV17C was used as a sensitive indicator strain for CbnA, while L. sakei DSM 20017 was used as a sensitive indicator for both CbnA and EntB. Immunity was tested by deferred inhibition assay (Ahn & Stiles, 1990) with C. piscicola LV17A or the EntB producer Enterococcus faecalis ATCC 19433 containing plasmid pCMAP03 (Franz et al., 1999) as producer strains, and strains containing immunity genes as indicators.
DNA manipulation, cloning and transformation. Large-and small-scale plasmid preparations from E. coli (Sambrook et al., 1989) and carnobacteria (Worobo et al., 1994 ; van Belkum & Stiles, 1995) were done by established techniques. Restriction endonucleases, T4 DNA ligase and Klenow enzyme were used as recommended by the suppliers (New England Biolabs ; Promega). DNA manipulations and cloning were done as described by Sambrook et al. (1989) . Competent cells of E. coli were prepared and transformed according to the onestep method of Chung et al. (1989) . Recombinant pMG36e plasmids were first transformed into E. coli MH1 before being transformed into LAB. Transformation of carnobacteria by electroporation was done by established methods (Worobo et al., 1995) and L. sakei DSM 20017 was transformed by the method of Berthier et al. (1996) . DNA sequence analysis. The nucleotide sequence was determined bidirectionally by Taq DyeDeoxy Cycle sequencing (Departments of Biochemistry or Biological Sciences, University of Alberta) on an Applied Biosystems 373A sequencer with stepwise deletion derivatives of cloned DNA fragments made with the Erase-a-Base system (Promega). A primerwalking strategy was used to complete small gaps in the nucleotide sequence. Synthetic oligonucleotides were made with an Applied Biosystems 391 PCR-Mate DNA synthesizer (Department of Biological Sciences, University of Alberta). Analysis of the nucleotide sequence was done with the DNA Strider (version 1.2) program. A search for homology of the predicted amino acid sequences was done with the  network service at the National Center for Biotechnology Information (NCBI). Homology comparisons and calculations were done with the  program.
Localization of the gene required for carnobacteriocin A immunity. A 10n0 kb PstI fragment from pCP49 was cloned into pCaT (Jewell & Collins-Thompson, 1989) , resulting in plasmid pRW01 (Table 1) . To localize the CbnA immunity gene, fragments of the 10n0 kb insert in pCAT were cloned into pMG36e and certain ORFs were disrupted by using internal restriction enzyme sites. First, a 5n4 kb XbaI-PstI fragment was excised from pRW01, blunt-ended and cloned into the SmaI site of the lactococcal shuttle vector pMG36e (van de Guchte et al., 1989) with the CbnA structural gene in the same orientation as the P32 promoter to yield plasmid pCF01 (Fig.  1) . A 3n1 kb PstI-SphI fragment was excised from pCF01 and cloned into pMG36e resulting in plasmid pCF02. Plasmid pCF03 was created by cutting pCF02 with PstI (located in the multiple cloning site) and at a unique BspM1 restriction site located within the 3n1 kb fragment. The plasmid was bluntended and self-ligated. Plasmids pCF04 to pCF07 were prepared using the same deletion technique (Table 1 , Fig. 1 ).
Preparation of the divergicin A signal peptide : : carnobacteriocin A structural gene fusion. Creation of a divergicin A (dvnA) signal peptide : : entB fusion construct was previously described (Franz et al., 1999) and this construct in plasmid pCMAP03 was transformed into Ent. faecalis ATCC 19433 to produce EntB by the general secretory pathway. To create the dvnA signal peptide : : cbnA fusion construct the primers CF-01 (5h-TAT AAA GCT TCT GCT GAC CAA ATG TCA GAT GGT GT-3h) and CF-02 (5h-TAT ACT GCA GCA TGC GAG TTT TTT ATT TCA TAC AGC TA-3h) were used. Primer CF-01 contained a HindIII restriction site (underlined) which, together with the next 5 nucleotides (CTGCT), encodes the carboxy terminus of the DNA encoding the DvnA signal peptide (Worobo et al., 1995 ; McCormick et al., 1996) . The nucleotides which follow CTGCT encode the amino terminus of mature CbnA and created an in-frame fusion of the 3h end of the DvnA signal peptide DNA and the CbnA structural gene. Primer CF-02 contained adjacent PstI and SphI restriction sites (underlined) and it is complementary to the 3h end of the CbnA structural gene. Using CF-01 and CF-02 as primers and pCF02 as template, DNA was amplified in 100 µl in 32 cycles (denaturation, 94 mC, 1 min ; annealing, 54 mC, 1 min ; extension, 72 mC, 1 min) using a temperature cycler (Omnigene, Intersciences). The PCR mixture contained 1n0 µM of each of the respective primers, 200 µM of dNTPs, 1 unit of TaqPlus Precision DNA polymerase and 1iTaqPlus Precision buffer (Stratagene). The PCR product was cloned into the PstI-HindIII sites of pUC118 for sequencing to confirm the fidelity of the reaction and for further cloning.
PCR amplification of the carnobacteriocin A and enterocin B
immunity genes. eniB (the EntB immunity gene) was previously amplified by PCR and cloned into plasmid pMG36e to yield pCMAP05 (Franz et al., 1999) as shown in Fig. 2 . cbiA (the CbnA immunity gene) was amplified by PCR using plasmid pCF02 as template. Primers CF-03 (5h-TAT ATC TAG AGA TCT AAT CAA AAT AAC TAG GA-3h) and CF-04 (5h-TAT AGG TAC CGT CTA CAG TCT GAA ACT AAA A-3h) were complementary to the 5h and 3h ends of this gene in pCF02, and contained XbaI and KpnI restriction enzyme sites, respectively (underlined). This PCR reaction was done as described for the dvnA signal peptide : : cbnA fusion above, except that an annealing temperature of 52 mC was used. The PCR product was cloned into pUC118 for sequencing to confirm the fidelity of the reaction. Plasmid pCF08 was created by cloning the cbiA PCR product into the XbaI-KpnI sites of pMG36e under the control of the P32 promoter (Fig. 2) .
Cloning of immunity genes behind the signal peptide : : bacteriocin fusion genes and heterologous expression. The PCR amplicon that initiates the dvnA signal peptide : : cbnA fusion was excised from pUC118 and cloned into the HindIII and KpnI sites of pRW19e to displace the part of the dvnA operon that encodes mature DvnA and the DvnA immunity protein (McCormick et al., 1996 ; Franz et al., 1999) to create an in-frame fusion of CbnA with the DvnA signal peptide (pCF09). Plasmid pCF10 was created by digesting pCMAP03 with XbaI and KpnI and inserting eniB (Franz et al., 1999) Induction factor synthesis and induction assays. The CbnA induction factor (CbaX) was synthesized at Anaspec Inc. (San Jose, CA, USA) and purified to 95 % homogeneity by reverse-phase (C ") ) HPLC using an acetonitrile\H # O gradient. The molecular mass of the peptide was verified by electrospray mass spectrometry. To assay for biological activity a 1 mM stock solution of CbaX was prepared in sterile distilled water. To lose bacteriocin activity (Bac -), a fully grown culture of C. piscicola LV17A was diluted 10'-fold in 5 ml APT broth, incubated at 25 mC and allowed to grow until turbid. Cell-free supernatant was assayed for loss of bacteriocin activity against C. piscicola LV17C. This Bac -culture was inoculated (1 %) into APT broth containing CbaX at concentrations ranging from 10 − & to 10 − "% mM and the subcultures were allowed to grow at 25 mC for 18 h and tested for bacteriocin production. Cell-free supernatant (1 %) of C. piscicola LV17A containing CbnA (3200 AU ml − ") was used in an induction test as a positive control.
RESULTS

Cloning and expression of the genes involved in carnobacteriocin A production
Transformation of C. piscicola LV17C with pRW01 resulted in full production of, and immunity to, CbnA. Plasmid pCF01, containing a 5n4 kb XbaI-PstI fragment from pRW01, was transformed into C. piscicola LV17C and resulted in full immunity without CbnA production (Fig. 1) . The complete nucleotide sequence of the 10 kb fragment was determined. It contains the previously sequenced 1n4 kb fragment encoding the CbnA structural gene and orfj1 (Fig. 1) be a candidate for the CbnA immunity gene (Worobo et al., 1994) . Downstream of orfj1 there are three small ORFs, one of which (orfj2) could encode a protein of 73 amino acids and partially overlaps orf-1. The other two ORFs, orf-1 and cbiA, are on the opposite strand, with translational products of 38 amino acids (orf-1) and 56 amino acids (cbiA). The products of orfj1, orfj2 and orf-1 did not show homology to amino acid sequences reported in protein databases, while CbiA showed homology to the EntB immunity protein EniB (see below). Downstream of these ORFs, the small ORF designated cbaX could encode a peptide of 41 amino acids. The deduced amino acid sequence of the N-terminus (residues 1-17) of CbaX showed homology to doubleglycine-type leader peptides. Immediately downstream of cbaX are two further ORFs (cbaK and cbaR) which could encode proteins of 425 and 245 amino acids, respectively. The protein products translated from cbaX, cbaK and cbaR revealed significant homologies to established three-component regulatory systems of class II bacteriocins. The highest homology was observed for the regulatory system involved in carnobacteriocin B2 production. The translational product of cbaX showed 92 % identity (96 % similarity) to the induction factor associated with production of carnobacteriocin B2 in C. piscicola LV17B (Quadri et al., 1997) . The translational products of cbaK and cbaR showed highest homology to the CbnB2 histidine protein kinase and response regulator (Table 2) , as well as high homology to equivalent proteins of other regulated bacteriocins. An ORF designated cbaT that could encode a protein containing 716 amino acids is located immediately downstream of cbaR, and it is followed by an ORF designated cbaC which could encode a 455 amino acid protein. The translational products of cbaT and cbaC show high homology to ABC-transporter and accessory proteins involved in the production of other class II bacteriocins. CbaT and CbaC shared highest homology with the secretion proteins of CbnB2 (Quadri et al., 1997) and they also showed homology to transporter proteins involved in secretion of EntA ( Table 2) .
Each of these ORFs is preceded by probable RBS. The putative promoter upstream of cbnA was described by Worobo et al. (1994) . A possible promoter sequence k35 (TTTAAT) and k10 (TACTTT) was found upstream of cbaX. Upstream of both cbnA and cbaX were conserved regulatory sequences consisting of right and left direct repeats. For cbnA the left (TTCAGG-ATA) and right (TTTAGGACA) direct repeat sequences are separated by 13 bases and the right repeat sequence was located 3 bases upstream of the presumptive k35 promoter sequence. For cbaX the left (TTCAAGACT) and right (TTCAGGATG) direct repeat sequences were also separated by 13 bases and the right repeat sequence was located three bases upstream of the presumptive k35 promoter sequence. Possible rho-independent terminators were identified after the cbnA and cbaC genes. No other ORFs could be identified in either strand of the 10n0 kb PstI fragment.
Induction of CbnA production with chemically synthesized, mature CbaX
The translation product of the putative induction factor gene cbaX contained 41 amino acids ; 17 of these were assumed to be the leader peptide, terminating with the typical Gly-Gly sequence, and the following 24 amino acids constituted the possible induction factor : SINSQ-IGKATSSISKCVFSFFKKC. The theoretical mass of this peptide was 2610n09 Da and the mass of the chemically synthesized CbaX determined by mass spectrometry was 2609n26 Da, possibly indicating a disulphide bridge between C"' and C#%. To determine whether the product of the cbaX gene is the induction factor for CbnA production, the chemically synthesized mature peptide was used to induce bacteriocin production in a Bac -culture of C. piscicola LV17A. When the induction factor was added at a concentration of 10 −"" M or higher, production of CbnA was induced, but not at concentrations of 10 −"# M or lower. Similarly, supernatant from a Bac + culture of C. piscicola LV17A used as a positive control induced bacteriocin production. The Bac -culture, when inoculated into APT broth without induction factor, failed to produce bacteriocin and served as a negative control.
Cloning and expression of the gene conferring immunity to carnobacteriocin A pCF01 lacked cbaC and the major part of cbaT and failed to produce bacteriocin, but it conferred full immunity when transformed into C. piscicola LV17C (Fig. 1) . The 3n1 kb PstI-SphI fragment in pCF02 conferred partial immunity to C. piscicola LV17C when tested against C. piscicola LV17A, indicated by a smaller zone of inhibition compared with that obtained with the sensitive C. piscicola LV17C strain. The 3n1 kb fragment differed from the 5n4 kb fragment in that cbnR and the major part of cbnK were deleted (Fig. 1) . Plasmid pCF03, which contains part of cbnA as well as orfj1, orfj2, orf-1, cbiA and cbaX, also conferred partial immunity to C. piscicola LV17C. Several other deletion derivatives were made (see Table 1 and Fig. 1 ) and cbiA was identified as the CbnA immunity gene. cbiA encodes a peptide of 56 amino acids which exhibits homology (30 % identity, 62 % similarity) with EniB, the 58 amino acid immunity peptide of EntB that is produced by Ent. faecium BFE 900 (Franz et al., 1999) (Fig. 3) . cbiA was amplified by PCR and cloned into the pMG36e expression vector (pCF08). cbiA in pCF08 conferred the same partial immunity phenotype as that observed for C. piscicola LV17C containing pCF02, 03, 04 or 06.
When cbiA was cloned together with either the dvnA signal peptide : : entB or the dvnA signal peptide : : cbnA gene fusion in L. sakei DSM 20017, full immunity was imparted to these heterologous hosts when tested against C. piscicola LV17A in the deferred inhibition tests (see below). .............................................................................................................................................................................................................................................................................................................   Fig. 3 . Alignment of (a) the carnobacteriocin A and enterocin B immunity proteins (CbiA and EniB, respectively) and (b) mature carnobacteriocin A and enterocin B (CbnA and EntB, respectively) by Lipman-Pearson alignment. Identical amino acids are shown ; similar amino acids are indicated by a colon sign. piscicola LV17C containing pCF11 against both indicators was smaller than that produced by the positive control C. piscicola LV17A containing pCP49. The zone of inhibition produced by C. piscicola LV17C containing pCF10 was also markedly smaller than that of L. sakei DSM 20017 containing this construct when tested against the L. sakei DSM 20017 indicator strain (9 vs 17 mm, respectively), whereas the inhibition zone produced by the L. sakei DSM 20017 containing pCF10 was comparable to that produced by the EntB-producing positive control Ent. faecalis ATCC 19433 containing pCMAP03. C. piscicola LV17C and L. sakei DSM 20017 containing either plasmid pCF12 or 13 were also tested for bacteriocin production against the indicators L. sakei DSM 20017 and C. piscicola LV17C. These clones expressed the same bacteriocins ; however, the immunity genes were interchanged (see below). Similar-sized zones of inhibition were observed as described above for these clones containing plasmids pCF10 or 11.
Expression of CbnA and EntB immunity genes and cross-immunity
C. piscicola LV17C containing plasmid pCF10, 11 or 13, and L. sakei DSM 20017 containing plasmid pCF10, 11 or 12, were tested as indicators for homologous or heterologous expression of immunity and cross-immunity with the EntB-producer Ent. faecalis ATCC 19433 containing pCMAP03, or the CbnA producer C. piscicola LV17A. Ent. faecalis ATCC 19433 containing pCMAP03 was active against L. sakei DSM 20017. Clones of L. sakei containing pCF10, 11 or 12 were fully immune to EntB. C. piscicola LV17C containing pCF10, 11 or 13 when tested as indicators in the deferred inhibition assay with C. piscicola LV17A as producer exhibited partial immunity, as shown by small zones of inhibition surrounding the producer (Fig. 4) . The largest zone of inhibition obtained with these clones was for C. piscicola LV17C containing the CbnA immunity gene on pCF11. However, when plasmids pCF10, 11 or 12 were contained in L. sakei DSM 20017 they imparted full immunity to CbnA (data not shown).
DISCUSSION
CbnA is one of three bacteriocins produced by the wildtype C. piscicola LV17 (Worobo et al., 1994) . Initial characterization of CbnA defined it as a class II bacteriocin that is produced as a prebacteriocin con-Genetic organization for carnobacteriocin A taining an N-terminal extension that is cleaved following a Gly(-2)-Gly(-1) processing site. Subsequently, Holck et al. (1994) purified the identical bacteriocin from C. piscicola LV61 and designated it piscicolin 61. These reports provided information only on the primary structure of the bacteriocin and cloning of the bacteriocin structural gene. To achieve full production of CbnA, it was necessary to include the 8n6 kb of DNA downstream of the structural gene. It was originally postulated that this region contained the dedicated secretion machinery for CbnA ; however, the results of this study show that, in addition to the two genes encoding the transport proteins, there are three genes associated with regulated production of bacteriocin. When the ORFs associated with CbnA production were analysed, highest homology was found with the CbnB2 secretion and regulation proteins, although the bacteriocins CbnA and CbnB2 show little homology. Based on their similarity to regulation and secretion proteins of other bacteriocin systems and, in particular, the striking similarity to those of CbnB2, the protein products of cbaX, cbaK and cbaR were assumed to be involved in CbnA regulation and those of cbaT and cbaC in the transport of CbnA. Evidence that the product of cbaX encodes an induction factor for CbnA regulation was obtained by chemical synthesis of mature CbaX devoid of the leader sequence and use of this peptide to induce CbnA production in a Bac -culture of C. piscicola LV17A. CbaX is produced intracellularly as a prepeptide containing a 17 amino acid leader peptide of the doubleglycine type, which is presumably removed by an ABC transporter during export from the cell. Bacteriocin production was induced at 10 −"" M. Concentrations of extracellular signal molecules of Gram-positive bacteria are known to exert biological activity in the nanomolar range or below (Dunny & Leonard, 1997 ; Nilsen et al., 1998) .
Most class II bacteriocins have a dedicated immunity gene that immediately follows the structural gene in an operon-type arrangement, the product of which protects the cell from its own bacteriocin (Nes et al., 1996) . This was not the case for CbnA. It resembles the case of EntB production from Ent. faecium BFE 900 and T136, in which the immunity gene was not found in an operon together with the bacteriocin structural gene, but was located immediately downstream of, and in opposite orientation to, the bacteriocin structural gene (Franz et al., 1999) . For CbnA, orfj1 was initially thought to encode the CbnA immunity protein (Worobo et al., 1994) ; however, when a 700 bp StuI-HindIII fragment containing this ORF was cloned and used in heterologous expression tests, immunity to CbnA was not observed (data not shown). In addition, absence of this ORF in pCF04 did not result in loss of the partial immunity phenotype. The gene conferring partial immunity to CbnA was identified by making sequential deletions of the 3n1 kb fragment in pCF02. When this gene (cbiA) was amplified by PCR and cloned into C. piscicola LV17C, it conferred the same level of partial immunity to this homologous host.
It is not clear why cbiA did not confer full immunity to C. piscicola LV17C, but a partial immunity phenotype has also been observed in other bacteriocin systems. Nisin immunity depends on the product of nisI, which is under common regulation with the nisA structural gene (Kuipers et al., 1993) . However, the nisE, nisF and nisG genes also are required for full immunity, and NisE and NisF show high homology to ABC transporter proteins (Siegers & Entian, 1995) . The cyclic peptide bacteriocin AS-48 produced by Ent. faecalis S-48 requires the product of the as-48D1 gene for immunity. In addition, the presence of the genes as-48B, C1 and D is required for full immunity (Martı! nez-Bueno et al., 1998) . It was suggested that these genes encode subunits of an ABC transporter (As-48C1 and As-48D) as well as a protein (As-48B) involved with bacteriocin maturation (Martı! nez-Bueno et al., 1998) . The ABC transporter protein involved with transport of lacticin 481 in Lactococcus lactis strains is assembled from three subunits that are encoded by the genes lctF, E and G. The presence of these three genes imparted full immunity to lacticin 481 (Rince! et al., 1997) . Therefore, ABC transporter proteins also may have an immunity function in some bacteriocin systems. However, in the case of CbnA immunity, the association of transport proteins with immunity was considered unlikely. Only the Nterminal part of the putative ABC transporter of CbnA was present in plasmid pCF01. Yet, in homologous expression experiments, this plasmid conferred full immunity to CbnA.
The change from a full to a partial immunity phenotype occurred only in the absence of functional CbnA histidine kinase and response regulator genes, suggesting that production of CbnA immunity may be regulated. This is supported by similar observations that inactivation of regulatory genes decreases immunity. The presence of the response regulator gene nisR was required for nisin production and this gene was also shown to regulate nisin immunity (van der Meer et al., 1993) . For the sakacin A system it was shown that inactivation of the histidine kinase or response regulator genes resulted in the loss of immunity (Axelsson & Holck, 1995) . For sakacin P, a frame-shift mutation in the histidine kinase gene also resulted in loss of immunity, while a deletion in the response regulator gene did not (Hu$ hne et al., 1996) . These results indicate that the immunity phenotype can be subject to regulation and that the partial immunity phenotype observed for CbnA immunity is probably a result of basal-level expression of the immunity gene. However, heterologous expression of cbiA in L. sakei DSM 20017 resulted in full immunity of this host to CbnA. A difference in expression levels or efficiency of this gene in these hosts may explain this observation compared with only partial immunity when cbiA was cloned in C. piscicola LV17C. The mechanism of regulation of immunity requires further study to explain the partial immunity phenotype observed here.
CbiA consists of 56 amino acids, which is two amino acids less than EniB. CbiA and EniB are very similar in that they are hydrophobic peptides which contain charged amino acids at the amino and carboxy ends (Fig. 3) . Using the PepTool protein structure prediction software both peptides were predicted to form an α-helix which may insert into the membrane. CbnA and EntB are Listeria-active bacteriocins, but they differ from other class II, especially class IIa bacteriocins, in that they do not contain a YGNGVXC consensus motif at the N-terminus of the mature bacteriocin peptide (Worobo et al., 1994 ; Casaus et al., 1997 ; Franz et al., 1999) . The immunity proteins of these bacteriocins and the mature bacteriocins have sequence similarity (30 and 45 % identity, respectively) as shown in Fig. 3 , and the immunity genes cbiA and eniB can be interchanged to cross-protect against EntB and CbnA. This is the first report of successful interchange of immunity genes in bacteriocin systems. The exact mechanism(s) by which immunity proteins function is not clear. It was suggested that immunity protein for CbnB2 blocked the pore formed by bacteriocins from the cytoplasmic side (Quadri et al., 1995) . Other immunity proteins, e.g. LafI and LciM (van Belkum et al., 1991 ; Allison & Klaenhammer, 1996) , were predicted to have transmembrane helices and therefore to be associated with the membrane. They may interact with the receptor for the bacteriocin and prevent binding of the bacteriocin to the membrane of the producer cell (Allison & Klaenhammer, 1996) . EniB and CbiA also have an α-helical domain that may insert into the membrane and prevent bacteriocin binding. The homology observed between the mature CbnA and EntB and between their respective immunity proteins raises the question whether these bacteriocins should in future be considered as a novel class of bacteriocins.
